HSBC/CALL/ABBOTT LABORATORIES/130/0.1/19.06.24 Share Price

Warrant

DE000HG4AN30

Real-time BOERSE MUENCHEN 10:36:47 23/05/2024 BST
0.016 EUR 0.00% Intraday chart for HSBC/CALL/ABBOTT LABORATORIES/130/0.1/19.06.24
6 months-60.00%
Current year-80.49%
Date Price Change
23/05/24 0.016 0.00%
22/05/24 0.016 0.00%
21/05/24 0.016 0.00%
20/05/24 0.016 0.00%
17/05/24 0.016 0.00%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 10:36 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer HSBC
WKN HG4AN3
ISINDE000HG4AN30
Date issued 23/06/2022
Strike 130 $
Maturity 19/06/2024 (28 Days)
Parity 10 : 1
Emission price 0.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.17
Lowest since issue 0.016
Spread 0.03
Spread %96.77%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.8 USD
Average target price
125.7 USD
Spread / Average Target
+19.91%
Consensus